Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CodeLab Capital ASOSL:CODE +11.80%55 3-Year EBITDA Growth Rate is 45.30% as of Dec. 2025, which is 36% above its 10-year median of 33.35. GuruFocus rates OSL:CODE with a GF Score™ of 55/100 and a GF Value™ of kr2.24 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 525 Healthcare Providers & Services companies, CodeLab Capital AS ranks better than 88.38% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 45.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of CodeLab Capital AS was 45.30% per year. The lowest was 21.40% per year. And the median was 33.35% per year.
CodeLab Capital AS (OSL:CODE) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
CodeLab Capital AS 3-Year EBITDA Growth Rate Related Terms
OSL:CODE vs VEEV, BTSG, HQY: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, CodeLab Capital AS's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CodeLab Capital AS 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CodeLab Capital AS's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where CodeLab Capital AS's 3-Year EBITDA Growth Rate falls into.
CodeLab Capital AS 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 45.30% mean?
CodeLab Capital AS (OSL:CODE) has a 3-Year EBITDA Growth Rate of 45.30% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for CodeLab Capital AS and its competitors. This is 36% above median its historical median of 33.35. Over the past decade, CodeLab Capital AS's 3-Year EBITDA Growth Rate has ranged from 21.40 to 45.30. According to the industry distribution chart, CodeLab Capital AS ranks #61 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 11.6%.
Is CodeLab Capital AS's 3-Year EBITDA Growth Rate too high?
CodeLab Capital AS's current 3-Year EBITDA Growth Rate of 45.30% is 36% above median its 10-year median of 33.35. Over the past 10 years, this metric has ranged from a low of 21.40 to a high of 45.30. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. CodeLab Capital AS's value of 45.30% is 344.1% above this industry median. Based on the distribution chart, CodeLab Capital AS ranks #61 out of 525 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, CodeLab Capital AS has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CodeLab Capital AS's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CodeLab Capital AS ranks #61 out of 525 companies for 3-Year EBITDA Growth Rate. This places CodeLab Capital AS in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.20. CodeLab Capital AS's value of 45.30% is 344.1% above this benchmark. Historically, CodeLab Capital AS's own 3-Year EBITDA Growth Rate has ranged from 21.40 to 45.30 over the past decade. While the company's 10-year median is 33.35 vs. the industry median of 10.20, CodeLab Capital AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CodeLab Capital AS's current 3-Year EBITDA Growth Rate of 45.30% is 344.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for CodeLab Capital AS and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CodeLab Capital AS's current 3-Year EBITDA Growth Rate is 45.30%, which is 36% above median its own 10-year median of 33.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CodeLab Capital AS stock overvalued right now?
Based on GuruFocus' analysis, CodeLab Capital AS (OSL:CODE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.24, compared to a current price of kr3.60 — trading 60.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 45.30%, which is 36% above median its 10-year median of 33.35 and 344.1% above the Healthcare Providers & Services industry median of 10.20. CodeLab Capital AS's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For CodeLab Capital AS (OSL:CODE), the current 3-Year EBITDA Growth Rate is 45.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CodeLab Capital AS (OSL:CODE) Overvalued in 2026?
Based on GuruFocus' analysis, CodeLab Capital AS stock appears to be overvalued.
The current stock price of kr3.60 is trading 60.7% above its estimated GF Value™ of kr2.24.
GuruFocus considers CodeLab Capital AS to be Significantly Overvalued.
Key valuation signals for OSL:CODE:
3-Year EBITDA Growth Rate: 45.30% (36% above median its 10-year median of 33.35)
GF Value™: kr2.24 vs. price of kr3.60 (60.7% above fair value)
Industry Position: 344.1% above the Healthcare Providers & Services median (#61 of 525)
No single metric tells the full story. See the OSL:CODE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CodeLab Capital AS builds and invests in next-generation technology. Its primary objective is to invest in other companies and contribute with capital, network, and operations. CodeLab Capital AS is a holding company that, through its subsidiary, is engaged in making software development tools for the broader B2B market.
55GF Score
Get the complete analysis for OSL:CODE
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CODE has been successfully added to your 
